Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Irritation and Sensitization of HP-5000
NCT04882319Phase 1Completed
- Sponsor
- Noven Pharmaceuticals
- Start
- Jun 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of HP-5000 placebo patch in knee osteoarthritis (OA), sponsored by Noven Pharmaceuticals. Primary endpoints: Mean Irritation Score at 21 days and Number and proportion of subjects sensitized at 21 days. Started Jun 2021; status: completed.
02
Drugs
HP-5000 placebo patch
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04882319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882319.